VANCOUVER, BC — The window of opportunity to participate in a new initiative tackling major threats posed by emerging pathogens and antimicrobial resistance is now open and BC researchers interested… Read More
Novartis has a long-standing history in Canada, and is committed to delivering improved outcomes for millions of patients. In 2022, Novartis invested a total of $450 million in Canada. The… Read More
Novel Trial to Study the Reduction of Certain Pathogens Following Scaling and Root Planing Procedure LAVAL, QC — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its oral health care business,… Read More
VANCOUVER, BC — (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced the departure of Neil Klompas, President and Chief Operating Officer…. Read More
VICTORIA, BC — /CNW/ — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced that… Read More
